Hu Yan-Yan, Chen Kai, Wang Lin-Lin, Wang Jia-Fang, Chen Xi, Cao Li-Juan, Jiang Qian, Wang Zhen-Xing, Qian Shan-Shan, Chen Zhi-Jun, Chen Liu-Qing, Li Dong-Sheng
Department of Dermatology, Wuhan No. 1 Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Hubei Key Laboratory of Infectious and Immune Skin Diseases, Wuhan No. 1 Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Front Med (Lausanne). 2023 May 24;10:1170520. doi: 10.3389/fmed.2023.1170520. eCollection 2023.
Hemoporfin-mediated photodynamic therapy (PDT) is an effective treatment for port-wine stains (PWS), and pain is the main adverse effect of this therapy. General anesthesia is commonly used for pain management during PDT, but the effect of general anesthetics on the subsequent treatment efficacy of PDT in PWS has not been reported.
To assess the use of general anesthesia combined with PDT compared with PDT alone in 207 PWS patients, and to provide further safety and efficacy data on this combined therapy.
Propensity score matching (PSM) was used at a 2:1 ratio to create a general anesthetic group ( = 138) and a highly comparable nonanesthetic group ( = 69). The clinical outcomes were evaluated, and the treatment reactions and adverse effects were recorded after one treatment with PDT.
After matching, there was no significant difference in the demographic data of the patients in the two groups ( > 0.05), while the treatment efficacy was significantly higher in the general anesthetic group than in the nonanesthetic group (76.81 vs. 56.52%, < 0.05). Moreover, logistic regression analysis confirmed that patients receiving general anesthesia showed an association with a good response to PDT (OR = 3.06; 95% CI, 1.57-6.00; = 0.0011). Purpura lasted longer in the general anesthetic group, but the other treatment reactions and adverse effects were similar in the two groups ( > 0.05). No serious systemic adverse reactions were observed.
We recommend this combined therapy, which is associated with painless, as a high efficacy treatment option for PWS patients, especially for patients with a poor response to multiple PDT alone treatments.
血卟啉介导的光动力疗法(PDT)是治疗鲜红斑痣(PWS)的一种有效方法,疼痛是该疗法的主要不良反应。在PDT治疗期间,全身麻醉常用于疼痛管理,但全身麻醉药对PDT后续治疗PWS疗效的影响尚未见报道。
评估207例PWS患者中全身麻醉联合PDT与单纯PDT的应用情况,并提供关于这种联合疗法的进一步安全性和有效性数据。
采用倾向评分匹配(PSM),以2:1的比例创建全身麻醉组(n = 138)和高度可比的非麻醉组(n = 69)。评估临床结局,并在PDT单次治疗后记录治疗反应和不良反应。
匹配后,两组患者的人口统计学数据无显著差异(P > 0.05),而全身麻醉组的治疗效果显著高于非麻醉组(76.81%对56.52%,P < 0.05)。此外,逻辑回归分析证实接受全身麻醉的患者与对PDT的良好反应相关(OR = 3.06;95%CI,1.57 - 6.00;P = 0.0011)。全身麻醉组紫癜持续时间更长,但两组的其他治疗反应和不良反应相似(P > 0.05)。未观察到严重的全身不良反应。
我们推荐这种联合疗法,其与无痛相关,作为PWS患者的一种高效治疗选择,特别是对于对多次单纯PDT治疗反应不佳的患者。